Shennon Biotechnologies: Funding, Investors & Team (Sep 2026)
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells, focusing on each cell individually, in order to create superior remedies for human diseases. It also assesses the operations of millions of immune cells to determine the most suitable objectives for cancer immunotherapy.
Shennon Biotechnologies has raised $13.0M across 1 funding round on record, the most recent a Seed of $13.0M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Shennon Biotechnologies Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Shennon Biotechnologies Funding Rounds
Shennon Biotechnologies Founders and Leadership Team
Contact details for the Shennon Biotechnologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Shennon Biotechnologies Funding Compared to Other Biotechnology Startups
Shennon Biotechnologies' latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Shennon Biotechnologies in Biotechnology and San Francisco
Companies Similar to Shennon Biotechnologies
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Shennon Biotechnologies Funding FAQs
What does Shennon Biotechnologies do?
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells, focusing on each cell individually, in order to create superior remedies for human diseases. It also assesses the operations of millions of immune cells to determine the most suitable objectives for cancer immunotherapy.
How much funding has Shennon Biotechnologies raised?
Shennon Biotechnologies has raised $13.0M across 1 round on record. The most recent is a Seed of $13.0M announced in Mar 2023.
When did Shennon Biotechnologies last raise funding?
Shennon Biotechnologies' most recent funding round on record is a Seed of $13.0M, announced in Mar 2023.
Who is the CEO of Shennon Biotechnologies?
Li Sun is listed as CEO at Shennon Biotechnologies.
Where is Shennon Biotechnologies headquartered?
Shennon Biotechnologies is based in San Francisco, California, United States.
How many employees does Shennon Biotechnologies have?
Shennon Biotechnologies is in the 11-50 employee band.
How does Shennon Biotechnologies' funding compare to other Biotechnology startups?
Shennon Biotechnologies' latest round of $13.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Shennon Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Shennon Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.